NovaBay Cost Of Revenue from 2010 to 2025

NBY Stock  USD 0.65  0.03  4.84%   
NovaBay Pharmaceuticals Cost Of Revenue yearly trend continues to be fairly stable with very little volatility. Cost Of Revenue will likely drop to about 4.7 M in 2025. During the period from 2010 to 2025, NovaBay Pharmaceuticals Cost Of Revenue regression line of annual values had r-squared of  0.0004 and arithmetic mean of  3,958,794. View All Fundamentals
 
Cost Of Revenue  
First Reported
2005-06-30
Previous Quarter
808 K
Current Value
848 K
Quarterly Volatility
1.4 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NovaBay Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 229.5 K, Interest Expense of 4.6 M or Other Operating Expenses of 16.9 M, as well as many indicators such as Price To Sales Ratio of 0.0638, Dividend Yield of 0.0 or PTB Ratio of 0.28. NovaBay financial statements analysis is a perfect complement when working with NovaBay Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NovaBay Pharmaceuticals Correlation against competitors.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.

Latest NovaBay Pharmaceuticals' Cost Of Revenue Growth Pattern

Below is the plot of the Cost Of Revenue of NovaBay Pharmaceuticals over the last few years. Cost of Revenue is found on NovaBay Pharmaceuticals income statement and represents the costs associated with goods and services NovaBay Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities. It is NovaBay Pharmaceuticals' Cost Of Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NovaBay Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Cost Of Revenue10 Years Trend
Very volatile
   Cost Of Revenue   
       Timeline  

NovaBay Cost Of Revenue Regression Statistics

Arithmetic Mean3,958,794
Geometric Mean1,864,344
Coefficient Of Variation95.68
Mean Deviation2,805,893
Median2,784,000
Standard Deviation3,787,747
Sample Variance14.3T
Range14.9M
R-Value0.02
Mean Square Error15.4T
R-Squared0.0004
Significance0.94
Slope15,989
Total Sum of Squares215.2T

NovaBay Cost Of Revenue History

20254.7 M
20246.1 M
20236.8 M
20226.6 M
20212.8 M
2020M
20191.7 M

About NovaBay Pharmaceuticals Financial Statements

NovaBay Pharmaceuticals investors use historical fundamental indicators, such as NovaBay Pharmaceuticals' Cost Of Revenue, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NovaBay Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue6.1 M4.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NovaBay Stock Analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.